MAZE THERAPEUTICS, INC. ETF Holding It
MAZE THERAPEUTICS, INC. (MAZE). 9 retained portfolio positions. Missing dates and values remain unreported.
- BBC: Fund Virtus Biotech Clinical Trials Etf; Weight 0.51%; Value (USD) $188.77K; Added / first observed 2025-07-31.
- FAD: Fund First Trust Multi Cap Growth AlphaDEX Fund; Weight 0.02%; Value (USD) $95.10K; Added / first observed 2026-04-30.
- FPX: Fund First Trust US Equity Opportunities ETF; Weight 0.06%; Value (USD) $753.98K; Added / first observed 2026-03-31.
- FSML: Fund Franklin Small Cap Enhanced ETF; Weight 0.07%; Value (USD) $81.49K; Added / first observed 2026-03-31.
ETF Holding It
9 retained portfolio positions. Missing dates and values remain unreported.
| ETF | Fund | Weight | Value (USD) | Added / first observed | Latest report |
|---|---|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 0.51% | $188.77K | 2025-07-31 | 2026-04-30 |
| FAD | First Trust Multi Cap Growth AlphaDEX Fund | 0.02% | $95.10K | 2026-04-30 | 2026-04-30 |
| FPX | First Trust US Equity Opportunities ETF | 0.06% | $753.98K | 2026-03-31 | 2026-03-31 |
| FSML | Franklin Small Cap Enhanced ETF | 0.07% | $81.49K | 2026-03-31 | 2026-03-31 |
| FYC | First Trust Small Cap Growth AlphaDEX Fund | 0.10% | $1.02M | 2026-04-30 | 2026-04-30 |
| GRX | Gabelli Healthcare & WellnessRx Trust | 0.00% | $2.98K | 2026-03-31 | 2026-03-31 |
| ISCB | iShares Morningstar Small-Cap ETF | 0.01% | $23.71K | 2026-01-31 | 2026-04-30 |
| IWV | iShares Russell 3000 ETF | 0.00% | $171.91K | 2025-12-31 | 2026-03-31 |
| PILL | Direxion Daily Pharmaceutical & Medical Bull 3X Shares | 0.71% | $90.93K | 2026-01-31 | 2026-04-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |